The IDIBAPS Executive Committee has approved the creation of the new research group. Ferran Nadeu, an R3B researcher, was previously part of the Mo...
A study led by Hospital Clínic-IDIBAPS sheds light on how this rare type of lymphoma evolves and why some tumor cells eventually outcompete others.
A study from Clínic-IDIBAPS published in Hemasphere provides a comprehensive molecular characterization of a rare tumour.
Ferran Nadeu, a researcher in the IDIBAPS research group Molecular pathology of lymphoid neoplasms located at Esther Koplowitz Centre, has been aw...
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
An international study, published in Nature Genetics, identifies more than 100 new genes involved in the disease and defines new groups of patients...
The partnership aims to improve current characterization and research practices of this disease.
The grants from the European Haematology Association (EHA) are aimed at promoting the early careers of researchers and encouraging their involvemen...
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS o...
